which methoxhexitone (barbiturates), ketamine (dissociative anesthetics), CT1341 (anesthetic steroids), diazepam and acetylpromazine (ataractics), and a fentanyl/fluanisone combination (neuroleptanalgesic) are the most valuable. Judicious combinations of these agents can contribute to total efficiency, yet maintain the animal in a light state of central nervous system narcosis. Toxicity of the clinical inhalational anesthetics, now extensively investigated in animals, is often related to their biotransformation products, some of which are poisonous.
One of the most dramatic examples of postanaesthetic toxicity occurs with fluroxene. This is a well-established agent for clinical use in humans, which has proved to be lethal in beagles, mongrel dogs, cats and rabbits (Johnston et al. 1973) . A similar lethality in mice and rats can be modified by stimulation or suppression of drug-metabolizing enzymes (Cascorbi & Singh-Amaranath 1973 , Harrison & Smith 1973 . Recently, female mice have been found to be less susceptible (Gorsky et al. 1975) . Trifluoroethanol is probably the principal toxic fluroxene metabolite (Johnston & Stevens 1972) but qualitative and quantitative differences between species complicate the extrapolation of these findings to primates and man (Munson et al. 1974 , Wardell 1973 .
Biotransformation of halothane and fluroxene in miniature swine (Sawyer et al. 1971 , Sawyer et al. 1972 ) and enflurane and methoxyflurane in rats (White et al. 1975 ) appears to be relatively morq efficient at low doses of anaesthetics. Many agents have now been investigated at subaneesthetic concentrations (Halsey et al. 1971) .
Chronic exposure exaggerates the production and toxicity of metabolites. Mice, rats, guineapigs and rabbits exposed to very low doses of halothane continuously for five weeks develop hepatic lesionsrabbits and guinea-pigs being the most susceptible (Stevens et al. 1975) . Similar experiments have now been done with low doses of fluroxene (Stevens & Gibbons 1973) . Current studies at the Clinical Research Centre, with Professor G G Harrison from Cape Town and Dr W D B Pope from Winnipeg, have demonstrated that the toxicity of chronic exposure of rats to 10-50 parts/106 of fluroxene is increased by pretreatment with phenobarbitone. The accidental discovery by Selye (1941) that certain steroid hormones had anaesthetic properties started the search for an intravenous steroid anasthetic.
The initial screening is in mice and gives information on speed of induction, potency, safety, and side-effects. The properties of an intravenous anesthetic are determined by its structure, lipid solubility, degree of ionization, rate of metabolism, redistribution in the tissues, protein binding, &c. Many structures are potentially suitable but they must also be lipid soluble and un-ionized to pass rapidly into the brain. If metabolism is rapid this controls the duration of action. If metabolism is slow redistribution controls duration and can lead to cumulation with repeated doses as the redistribution sites become saturated.
Pregnanes with a free 3a-hydroxy group are rapidly acting and potent, but insoluble in water.
Esterificalion at 3 or 21 reduces activity. Alphaxolone (3a-hydroxy-5a-pregnane-11,20-dione) when mixed with its 21-acetoxy derivative could be dis-solved in macrogol ether (Cremophor EL) to give the injectable anesthetic CTI 341 (Althesin) (Child et al. 1971) . CT 1341 was rapidly metabolized and showed little cumulation on repeated injection into mice and cats. The general properties of CT 1341 and its possible interactions with conventional anaesthetics and adjuvants were investigated. CT 1341 can be used as an induction agent or by repeated injection or infusion. The search for a simple water soluble steroid anaesthetic continues.
